Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.

Cell chemical biology | 2019

The target profiles of many drugs are established early in their development and are not systematically revisited at the time of FDA approval. Thus, it is often unclear whether therapeutics with the same nominal targets but different chemical structures are functionally equivalent. In this paper we use five different phenotypic and biochemical assays to compare approved inhibitors of cyclin-dependent kinases 4/6-collectively regarded as breakthroughs in the treatment of hormone receptor-positive breast cancer. We find that transcriptional, proteomic, and phenotypic changes induced by palbociclib, ribociclib, and abemaciclib differ significantly; abemaciclib in particular has advantageous activities partially overlapping those of alvocidib, an older polyselective CDK inhibitor. In cells and mice, abemaciclib inhibits kinases other than CDK4/6 including CDK2/cyclin A/E-implicated in resistance to CDK4/6 inhibition-and CDK1/cyclin B. The multifaceted experimental and computational approaches described here therefore uncover underappreciated differences in CDK4/6 inhibitor activities with potential importance in treating human patients.

Pubmed ID: 31178407 RIS Download

Additional research tools detected in this publication

None found

Associated grants

  • Agency: NIGMS NIH HHS, United States
    Id: P50 GM107618
  • Agency: NCI NIH HHS, United States
    Id: U54 CA225088
  • Agency: NHLBI NIH HHS, United States
    Id: U54 HL127365

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Vimentin (D21H3) XP Rabbit mAb (Alexa Fluor 555 Conjugate) (antibody)

RRID:AB_10859896

This monoclonal targets Vimentin (D21H3) XP Rabbit mAb (Alexa Fluor 555 Conjugate)

View all literature mentions

Phospho-Rb (Ser807/811) (D20B12) XP® (Alexa Fluor® 555 Conjugate) (antibody)

RRID:AB_2728827

This monoclonal targets Rb phosphorylated at Ser807, Ser811

View all literature mentions

Rb (4H1) Mouse mAb (antibody)

RRID:AB_823629

This monoclonal targets Rb (4H1) Mouse mAb

View all literature mentions

Crl:NU-Foxn1nu (organism)

RRID:IMSR_CRL:088

Mus musculus with name Crl:NU-Foxn1nu from IMSR.

View all literature mentions

SUM149PT (cell line)

RRID:CVCL_3422

Cell line SUM149PT is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

SK-BR-3 (cell line)

RRID:CVCL_0033

Cell line SK-BR-3 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

SUM1315MO2 (cell line)

RRID:CVCL_5589

Cell line SUM1315MO2 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

MDA-MB-453 (cell line)

RRID:CVCL_0418

Cell line MDA-MB-453 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

SUM159PT (cell line)

RRID:CVCL_5423

Cell line SUM159PT is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

MCF-10A (cell line)

RRID:CVCL_0598

Cell line MCF-10A is a Spontaneously immortalized cell line with a species of origin Homo sapiens

View all literature mentions

MDA-MB-157 (cell line)

RRID:CVCL_0618

Cell line MDA-MB-157 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

hTERT-HME1 (cell line)

RRID:CVCL_3383

Cell line hTERT-HME1 is a Telomerase immortalized cell line with a species of origin Homo sapiens (Human)

View all literature mentions

MDA-MB-361 (cell line)

RRID:CVCL_0620

Cell line MDA-MB-361 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HCC1500 (cell line)

RRID:CVCL_1254

Cell line HCC1500 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HCC1937 (cell line)

RRID:CVCL_0290

Cell line HCC1937 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HCC1419 (cell line)

RRID:CVCL_1251

Cell line HCC1419 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HCC38 (cell line)

RRID:CVCL_1267

Cell line HCC38 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

CAL-120 (cell line)

RRID:CVCL_1104

Cell line CAL-120 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

CAL-85-1 (cell line)

RRID:CVCL_1114

Cell line CAL-85-1 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

BT-20 (cell line)

RRID:CVCL_0178

Cell line BT-20 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HCC1143 (cell line)

RRID:CVCL_1245

Cell line HCC1143 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

T-47D (cell line)

RRID:CVCL_0553

Cell line T-47D is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

MDA-MB-468 (cell line)

RRID:CVCL_0419

Cell line MDA-MB-468 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

MDA-MB-436 (cell line)

RRID:CVCL_0623

Cell line MDA-MB-436 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

MDA-MB-231 (cell line)

RRID:CVCL_0062

Cell line MDA-MB-231 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

MCF-7 (cell line)

RRID:CVCL_0031

Cell line MCF-7 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

Hs 578T (cell line)

RRID:CVCL_0332

Cell line Hs 578T is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HCC70 (cell line)

RRID:CVCL_1270

Cell line HCC70 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HCC1954 (cell line)

RRID:CVCL_1259

Cell line HCC1954 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HCC1806 (cell line)

RRID:CVCL_1258

Cell line HCC1806 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HCC1428 (cell line)

RRID:CVCL_1252

Cell line HCC1428 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HCC1395 (cell line)

RRID:CVCL_1249

Cell line HCC1395 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

CAMA-1 (cell line)

RRID:CVCL_1115

Cell line CAMA-1 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

CAL-51 (cell line)

RRID:CVCL_1110

Cell line CAL-51 is a Cancer cell line with a species of origin Homo sapiens

View all literature mentions

BT-549 (cell line)

RRID:CVCL_1092

Cell line BT-549 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions